Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
HHS’s move Monday to overhaul the childhood vaccine schedule without public input marks Health Secretary Robert F. Kennedy Jr ...
TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...
Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...
Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...
Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles ...
Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...
According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...
The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...
Negative symptoms of schizophrenia affect motivation, emotion, and daily life. Learn the signs, why they’re often missed, and ...
When people hear the word veterinarian, the first image that often comes to mind is a doctor tending to household pets like ...
Variant Bio, a genomics-driven AI drug discovery company, today announced a multi-year research collaboration and license agreement with Boehringer Ingelheim. The partnership will focus on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback